ImmunityBio
IBRX
$5.49
Share price
11.13%
Change (1 day)
125.00%
Change (1 year)
Categories
P/S ratio for ImmunityBio (IBRX)
P/S ratio as of April 2024 (TTM): > 1000
According to ImmunityBio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5975.48. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for ImmunityBio from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | -36.27% |
| 2022 | > 1000 | 226.56% |
| 2021 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |